Abbvie
Global biopharmaceutical company
Based in IL
🤖
AI Overview
With $2.0M in lobbying spend across 32 quarterly filings, Abbvie is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2025.
$2.0M
Total Spend
8
Years Active
1
Firms Hired
6
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $240K |
| 2020 | $240K |
| 2021 | $240K |
| 2022 | $240K |
| 2023 | $240K |
| 2024 | $240K |
| 2025 | $320K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation
- •Legislative services related to H.R. 1, Bill to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (bill formerly known as the Tax C
- •Legislative services related to Public Law 115-97 (Tax Cuts and Jobs Act) and tax issues related to Puerto Rico.
Related Analysis
Related Investigations
Similar Clients
Health Care Service Corporation, a Mutual Legal Reserve Company (Hcsc)
$52.8M total spend
Horizon Therapeutics USA, INC. (FKA Horizon Pharma USA, INC.)
$33.6M total spend
Advocate Aurora Health, INC.
$16.8M total spend
International Motors, LLC (Formerly Navistar, INC)
$9.7M total spend
Bmo Bank N.a. (FKA Bmo Harris Bank N.a.)
$6.3M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.